National Heart, Lung, and Blood Institute; Notice of Closed Meetings, 57866 [2013-22866]
Download as PDF
57866
Federal Register / Vol. 78, No. 183 / Friday, September 20, 2013 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
Final Deadline for Submission of written
comments: Wednesday, October 2, 2013 by
5:00 p.m. e.t.
Please note: The NIMH Office of Autism
Research Coordination (OARC) anticipates
that written public comments received by the
deadline of 5:00 p.m. e.t., Wednesday,
October 2, 2013 will be presented to the
Committee prior to the October 9th meeting
for the Committee’s consideration. Any
written comments received after the October
2, 2013 deadline (between October 3, 2013
and October 8, 2013) will be provided to the
Committee either before or after the meeting,
depending on the volume of comments
received and the staff time required to
process them in accordance with privacy
regulations and other applicable Federal
policies.
Access: Twinbrook Metro (Red Line).
Contact Person: Ms. Lina Perez, Office of
Autism Research Coordination, National
Institute of Mental Health, NIH, 6001
Executive Boulevard, Room 6182A, Bethesda,
MD 20892–9669, Phone: 301–443–6040,
Email: IACCPublicInquiries@mail.nih.gov.
Public Comments
Any member of the public interested in
presenting oral comments to the Committee
must notify the Contact Person listed on this
notice by 5:00 p.m. ET on Friday, September
27, 2013, with their request to present oral
comments at the meeting. Interested
individuals and representatives of
organizations must submit a written/
electronic copy of the oral presentation/
statement including a brief description of the
organization represented by 5:00 p.m. E.T. on
Wednesday, October 2, 2013. Statements
submitted will become a part of the public
record. Only one representative of an
organization will be allowed to present oral
comments and presentations will be limited
to three to five minutes per speaker,
depending on the number of speakers to be
accommodated within the allotted time.
Speakers will be assigned a time to speak in
the order of the date and time when their
request to speak is received, along with the
required submission of the written/electronic
statement by the specified deadline.
In addition, any interested person may
submit written comments to the IACC prior
to the meeting by sending the comments to
the Contact Person listed on this notice by
5:00 p.m. ET on Wednesday, October 2, 2013.
The comments should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person. NIMH
anticipates written public comments received
by 5:00 p.m. E.T., Wednesday, October 2,
2013 will be presented to the Committee
prior to the meeting for the Committee’s
consideration. Any written comments
received after the October 2, 2013 deadline
(between October 3, 2013 and October 8,
2013) will be provided to the Committee
either before or after the meeting, depending
on the volume of comments received and the
staff time required to process them in
accordance with privacy regulations and
other applicable Federal policies. All written
public comments and oral public comment
statements received by the deadlines for both
VerDate Mar<15>2010
17:24 Sep 19, 2013
Jkt 229001
oral and written public comments will be
provided to the IACC for their consideration
and will become part of the public record.
Core Values
In the 2009 IACC Strategic Plan, the IACC
listed the ‘‘Spirit of Collaboration’’ as one of
its core values, stating that, ‘‘We will treat
others with respect, listen to diverse views
with open minds, discuss submitted public
comments, and foster discussions where
participants can comfortably offer opposing
opinions.’’ In keeping with this core value,
the IACC and the NIMH Office of Autism
Research Coordination (OARC) ask that
members of the public who provide public
comments or participate in meetings of the
IACC also seek to treat others with respect
and consideration in their communications
and actions, even when discussing issues of
genuine concern or disagreement.
Remote Access
The meeting will be open to the public
through a conference call phone number and
webcast live on the Internet. Members of the
public who participate using the conference
call phone number will be able to listen to
the meeting but will not be heard. If you
experience any technical problems with the
web cast or conference call, please send an
email to helpdeskiacc@gmail.com or by
phone at 415–652–8023.
Special Accommodations
Individuals who participate in person or by
using these electronic services and who need
special assistance, such as captioning of the
conference call or other reasonable
accommodations, should submit a request to
the Contact Person listed on this notice at
least 5 days prior to the meeting.
Security
As a part of security procedures, attendees
should be prepared to present a photo ID at
the meeting registration desk during the
check-in process. Pre-registration is
recommended. Seating will be limited to the
room capacity and seats will be on a first
come, first served basis, with expedited
check-in for those who are pre-registered.
Meeting schedule subject to change.
Information about the IACC is available on
the Web site: https://www.iacc.hhs.gov.
Dated: September 12, 2013.
Carolyn Baum,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–22867 Filed 9–19–13; 8:45 am]
BILLING CODE 4140–01–P
The meetings will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Sample Biorepository and Laboratory Center
for Myeloid Dysplasia Diseases.
Date: October 10, 2013.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael P Reilly, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7200, Bethesda, MD 20892, 301–496–9659,
reillymp@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel;
Data Center for Myeloid Dysplasia Diseases.
Date: October 10, 2013.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Doubletree Hotel Bethesda
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael P Reilly, Ph.D.,
Scientific Review Officer, Office of Scientific
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7200, Bethesda, MD 20892, 301–496–9659,
reillymp@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: September 13, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2013–22866 Filed 9–19–13; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\20SEN1.SGM
20SEN1
Agencies
[Federal Register Volume 78, Number 183 (Friday, September 20, 2013)]
[Notices]
[Page 57866]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-22866]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended.
The contract proposals and the discussions could disclose confidential
trade secrets or commercial property such as patentable material, and
personal information concerning individuals associated with the
contract proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Sample Biorepository and Laboratory Center
for Myeloid Dysplasia Diseases.
Date: October 10, 2013.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael P Reilly, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7200, Bethesda, MD
20892, 301-496-9659, reillymp@nhlbi.nih.gov.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Data Center for Myeloid Dysplasia Diseases.
Date: October 10, 2013.
Time: 12:30 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: Doubletree Hotel Bethesda (Formerly Holiday Inn Select),
8120 Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Michael P Reilly, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room 7200, Bethesda, MD
20892, 301-496-9659, reillymp@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: September 13, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-22866 Filed 9-19-13; 8:45 am]
BILLING CODE 4140-01-P